Expleo Solutions
EXPLEOSOLInformation Technology
Quarterly structural health evolution — tracking what changed beneath the surface across each reporting period.
Quarterly History
🚨 Structural Deterioration Signature: In Q2 FY2027, Expleo Solutions reported a 2.4% YoY revenue growth to ₹302.6 Cr, but net profit contracted by 8.5% to ₹36.4 Cr, with EBITDA margins compressing by 3.4 pp to 16.7%. This deterioration persists across interim quarters since FY2026, with Q1 FY2027 showing 12.0% revenue growth and Q2 FY2027 confirming a 2.4% YoY revenue expansion, though net profit remained under sector median performance. The operational strain is compounded by elevated governan
Expleo Solutions posted steady top-line growth and bottom-line stability, demonstrating resilient execution in its core markets. While the underlying business remains fundamentally sound, the presence of 1 active risk warnings highlights minor operational or working capital inefficiencies to keep on the watch list.